electroCore, Inc. (ECOR)

Recent Quarterly Results

Source: Company filings

Price Chart

electroCore, Inc. (ECOR) stock price: $4.73 (+0.18, +3.96%)

Why Bull

• •Recent insider buying suggests confidence in electroCore's future, indicating that key stakeholders believe in the company's potential.
• •Community sentiment has shifted positively, with discussions around the efficacy of their non-invasive therapies gaining traction.
• •Analysts are highlighting the growing interest in neuromodulation therapies, positioning electroCore favorably within a burgeoning market.
• •Recent partnerships and collaborations have sparked optimism about expanding their product reach and enhancing brand visibility.

Why Bear

• •Concerns linger over the company's revenue growth, as some investors are skeptical about the scalability of their current offerings.
• •Social sentiment reflects apprehension about regulatory hurdles that could delay product approvals and market entry.
• •There is a notable divide in community views, with some traders expressing doubts about the long-term viability of their business model.
• •Recent market developments have introduced competition, raising questions about electroCore's ability to maintain its market position.

• Earnings Scheduled For November 5, 2025
  benzinga · Nov 5, 2025
• Earnings Scheduled For August 6, 2025
  benzinga · Aug 6, 2025
• Earnings Scheduled For May 7, 2025
  benzinga · May 7, 2025
• Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
  benzinga · Jan 17, 2023

Rationale

AI-generated technical analysis for ECOR including trend direction, momentum, and pattern recognition.

What to Watch

Key support and resistance levels, volume signals, and upcoming events.

Risk Management

Position sizing, stop-loss levels, and risk-reward assessment.

Set your price target for electroCore, Inc. (ECOR), choose a timeframe, and track your prediction accuracy.

Current price: $4.73

Score Factors

• Revenue Growth 8/100

  Revenue grew 57.1% YoY, showing strong top-line momentum well above industry average.

• Gross Margin 10/100

  Gross margin of 86.0% shows excellent pricing power and a strong competitive moat.

• Operating Leverage 6/100

  Revenue growth is driving operating leverage, meaning profits can grow faster than costs.

• Cash Runway 5/100

  Cash position data is currently unavailable for this company.

• R&D Intensity 5/100

  R&D spending data is currently unavailable for this company.

• Insider Activity 10/100

  Insiders bought +$2.34M net in recent filings, a strong confidence signal from those who know the company best.

• Short Interest 5/100

  Float and volume data unavailable for liquidity analysis.

• Price Momentum 0/100

  No bullish technical signals detected. The stock lacks upward price momentum currently.

• News Sentiment 5/100

  No sentiment data available

What does this score mean?

The MoonshotScore rates ECOR's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

What does electroCore, Inc. do?

electroCore, Inc. is a commercial-stage medical device company specializing in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies. Their primary product, gammaCore Sapphire, is a prescription-only handheld device designed for the acute treatment of pain associated with migraine and episodic cluster headache in adults. The company focuses on providing patients with a non-pharmacological alternative for pain management, utilizing neuromodulation to stimulate the vagus nerve and alleviate symptoms. electroCore's business model centers around the sale of gammaCore Sapphire devices and related accessories, targeting both patients and healthcare providers.

Is ECOR stock a good buy?

ECOR stock presents a mixed investment profile. The company's high gross margin of 86.0% indicates strong pricing power, and the potential for growth in the neuromodulation market is significant. However, the company's negative P/E ratio of -3.25 and a profit margin of -47.5% reflect its current lack of profitability. Investors should consider the potential for future growth driven by expanding indications and geographic reach, but also be aware of the risks associated with a small market capitalization and reliance on a single product. A balanced analysis suggests that ECOR may be suitable for investors with a high-risk tolerance and a long-term investment horizon.

What are the main risks for ECOR?

electroCore faces several key risks. Competition from larger, more established medical device companies poses a significant threat. Regulatory hurdles for new indications of gammaCore Sapphire could delay or prevent market expansion. Reimbursement challenges from insurance providers could limit patient access to the device. Product liability claims related to gammaCore Sapphire could negatively impact the company's financial performance. Finally, the company's dependence on a single product for revenue makes it vulnerable to changes in market demand or technological advancements.

Is ECOR a good stock to buy?

Whether ECOR is a good investment depends on your financial goals, risk tolerance, and investment horizon. Key factors to evaluate include the company's revenue growth trajectory, profit margins, debt-to-equity ratio, competitive moat, and valuation multiples (P/E, P/S, EV/EBITDA) relative to industry peers. Our AI-generated Investment Thesis and SWOT analysis on this page provide a data-driven starting point. Always do your own research and consider consulting a financial advisor before making investment decisions.

What is the ECOR MoonshotScore?

The MoonshotScore for ECOR is an AI-powered rating from 0 to 100 that evaluates a stock across four dimensions: growth potential (revenue and earnings trajectory), financial health (balance sheet strength, cash flow), market momentum (price trends, volume patterns, institutional flows), and risk factors (volatility, debt levels, sector headwinds). Scores above 70 indicate strong potential, 50-70 moderate, and below 50 suggests caution. The score is recalculated daily using the latest financial data and market signals.

How often is ECOR data updated?

ECOR stock prices are updated in real-time during U.S. market hours (9:30 AM - 4:00 PM ET, Monday through Friday). After-hours and pre-market prices are also tracked. Company fundamentals (earnings, revenue, balance sheet) are refreshed when new quarterly or annual reports are filed. Analyst ratings, price targets, and AI-generated insights are updated daily. Breaking news related to ECOR is aggregated continuously from premium financial news sources throughout the day.

What are the growth catalysts for ECOR?

Growth catalysts for electroCore, Inc. (ECOR) can include several categories: product catalysts (new launches, FDA approvals, patent grants), financial catalysts (earnings beats, margin expansion, share buybacks), strategic catalysts (acquisitions, partnerships, market expansion into new regions), and macro catalysts (favorable regulation, industry tailwinds, secular growth trends). Our AI analyzes electroCore, Inc.'s specific catalysts using earnings transcripts, SEC filings, and news sentiment to identify the most impactful near-term and long-term drivers.

Who are ECOR's main competitors?

electroCore, Inc. (ECOR) competes with companies in its industry that target similar customers, markets, or product categories. Competitor analysis involves comparing key metrics: market share, revenue growth rates, profit margins, R&D spending, and valuation multiples. Understanding competitive positioning helps investors assess whether ECOR has a sustainable competitive advantage (moat) through brand strength, network effects, cost leadership, or switching costs. Our Competitors section provides a side-by-side comparison with relevant peers.

What do analysts say about ECOR?

Wall Street analyst coverage for ECOR includes consensus ratings (buy, hold, or sell), 12-month price targets, and earnings estimates. Analyst opinions are aggregated from major investment banks and research firms. Key metrics to watch include the consensus price target (average, high, and low estimates), the number of analysts covering the stock, any recent rating changes (upgrades or downgrades), and how actual earnings compare to analyst estimates (beat or miss history). Our platform aggregates these from multiple data providers for a comprehensive view.

What is ECOR's market cap?

Market capitalization (market cap) for ECOR is calculated by multiplying the current share price by the total number of outstanding shares. It represents the market's total valuation of the company. Stocks are typically categorized as mega-cap ($200B+), large-cap ($10B-$200B), mid-cap ($2B-$10B), small-cap ($300M-$2B), or micro-cap (under $300M). Market cap influences index inclusion, institutional ownership eligibility, and risk profile. Our Key Statistics section shows ECOR's current market cap alongside enterprise value and other valuation metrics.

How has ECOR stock performed recently?

ECOR's recent stock performance can be evaluated across multiple timeframes: daily price changes, week-over-week momentum, monthly trends, and year-to-date returns. Important performance indicators include the stock's 52-week high and low, moving averages (50-day and 200-day SMA), relative strength index (RSI), and volume trends. Comparing ECOR's performance against its sector index and the S&P 500 provides context on whether it is outperforming or underperforming the broader market.

What are the risks of investing in ECOR?

Key risk categories for ECOR include: market risk (overall market downturns affecting stock prices), company-specific risk (management changes, product failures, competitive threats), financial risk (high debt levels, cash burn, dilution from stock issuance), regulatory risk (government policy changes, lawsuits, compliance issues), and macroeconomic risk (interest rate changes, inflation, currency fluctuations). Beta measures ECOR's volatility relative to the market - a beta above 1.0 means higher volatility than the S&P 500. Our AI-generated risk assessment identifies the most relevant risk factors for this specific stock.

Are insiders buying or selling ECOR?

Insider trading activity for ECOR tracks purchases and sales by company executives, directors, and major shareholders (10%+ owners) as reported in SEC Form 4 filings. Insider buying is generally considered a bullish signal because insiders have the deepest knowledge of company operations, while selling may have various motivations (diversification, tax planning, pre-planned 10b5-1 trading plans). Key metrics include the buy-to-sell ratio, total dollar value of insider transactions, and whether multiple insiders are trading in the same direction. Our Insider Flow tab shows recent transactions with dates and dollar amounts.

Is ECOR a good stock for beginners?

electroCore, Inc. (ECOR) can be suitable for beginner investors depending on several factors. Look at the MoonshotScore on this page for an overall AI-powered assessment of growth potential and risk. Beginners should also check the company's market cap (larger companies tend to be less volatile), gross margin (higher margins mean stronger business fundamentals), and cash position (healthy cash reduces bankruptcy risk). Always start with a small position size and never invest money you cannot afford to lose.

How risky is ECOR for first-time investors?

Every stock carries risk, including electroCore, Inc. (ECOR). First-time investors should review the Risk Factors section on this page for company-specific risks. Key risk indicators include price volatility (check the chart for daily swings), insider selling activity (see Insider Flow tab), and cash runway (see MoonshotScore breakdown). A diversified portfolio with an index fund like the S&P 500 as a core holding is generally recommended before adding individual stocks like ECOR.